health
Preprint reports lenalidomide-triggered safety switch for engineered T cells
A bioRxiv preprint describes a genetic switch that uses lenalidomide to trigger the death of engineered human T cells, including CAR T cells. The work reports preclinical cell experiments, not clinical testing.